Related Experiment Video
Updated: May 30, 2026
08:53
Assessing Neuroprotective Effects of Glycyrrhizae Radix et Rhizoma Extract Using a Transient Middle Cerebral Artery Occlusion Mouse Model
Published on: December 9, 2018
In silico pharmacology suggests ginger extracts may reduce stroke risks
Tung-Ti Chang1, Kuan-Chung Chen, Kai-Wei Chang
1Laboratory of Computational and Systems Biology, School of Chinese Medicine, China Medical University, Taichung, 40402, Taiwan.
Molecular Biosystems
|July 22, 2011
Summary
Researchers identified ginger-derived compounds as potential inhibitors of PDE4D, a key target for preventing stroke and cardiovascular diseases by modulating cyclic adenosine monophosphate (cAMP) signaling.
Area of Science:
- Pharmacology
- Computational Chemistry
- Drug Discovery
Background:
- Aberrant cyclic adenosine monophosphate (cAMP) signaling is linked to allergic responses, stroke, and cardiovascular diseases.
- Phosphodiesterase 4D (PDE4D) plays a crucial role in cAMP regulation and is a potential therapeutic target for stroke prevention.
Purpose of the Study:
- To identify potential PDE4D inhibitors from traditional Chinese medicine (TCM) using machine learning.
- To validate the efficacy and binding characteristics of identified compounds against PDE4D.
Main Methods:
- Screening of a TCM database using machine learning models (MLR, SVM).
- Molecular dynamics simulations to assess binding stability and intermolecular interactions.
- Pharmacophore mapping using HypoGen validation.
Main Results:
- Machine learning models demonstrated high predictive accuracy (R²=0.8234 for MLR, R²=0.7854 for SVM).
- Three compounds from the ginger family were identified as potential PDE4D inhibitors.
- Molecular dynamics and pharmacophore analysis confirmed the inhibitory potential and binding characteristics of the ginger compounds.
Conclusions:
- The identified ginger compounds effectively inhibit PDE4D's binding and hydrolysis of cAMP.
- These compounds represent promising leads for developing novel therapeutic strategies for stroke and cardiovascular disease prevention.
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.